Siemens and Dräger are expanding their partnership

Drägerwerk AGDräger acquires 10 percent of Siemens AG shares in its Joint Venture Dräger Medical AG & Co. KG for a sales price of approximately 110 million EUR and increases its stake to 75 percent. At the same time, Siemens AG waves the sales option of its shares originally agreed in the Joint Venture contract and retains its 25 percent holding in the Dräger Medical Group. In addition, Siemens AG plans to purchase 2.5 percent of the Drägerwerk AG, probably in the form of common stock to be issued in the future.

"With an investment in Drägerwerk AG, we document that we want to intensify and continue our partnership," emphasizes Erich R. Reinhardt, member of the Executive Board of Siemens AG and CEO and President of Siemens Medical Solutions. "We have reached an excellent competitive position and are growing faster than the market," added Stefan Dräger, Chairman of Drägerwerk AG. Both companies have contributed to the development of Dräger Medical into one of the leading international manufacturers of medical therapy systems.

In 2003, Drägerwerk AG and Siemens AG founded the Joint Venture Dräger Medical AG & Co. KG, Lübeck. For fiscal year 2006, the total number of employees was at approximately 6,000, and sales of approx. 1.2 billion EUR and an EBIT of approximately 110 million EUR is expected.

Drägerwerk AG is an international leader in the markets for medical and safety technology. In 2005, this technology group generated sales of €1,630.8 million. Founded in 1889, Dräger, Lübeck, nowadays employs around 9,700 people in more than 190 countries, hereof more than 50 percent outside of Germany. The Dräger Medical subgroup offers products and services plus integrated system solutions along the entire patient process chain in the CareAreas™ emergency care, perioperative care, critical and perinatal care, as well as home care. The Dräger Safety subgroup's portfolio covers products and system solutions for holistic hazard management: gas detection, personal and property protection products including a wide variety of services. For further information, visit www.draeger.com.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...